The TGF‐β‐Th2 axis: A new target for cancer therapy?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Allergy (Copenhagen) 2021-11, Vol.76 (11), p.3563-3565
Hauptverfasser: García de Durango, Cira Rosario, Escribese, Maria M., Rosace, Domenico
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3565
container_issue 11
container_start_page 3563
container_title Allergy (Copenhagen)
container_volume 76
creator García de Durango, Cira Rosario
Escribese, Maria M.
Rosace, Domenico
description
doi_str_mv 10.1111/all.14965
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2534617050</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2534617050</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3305-177789604231c05782db7fa171e22c0f9798a88c7a884d6d040f2b0b8f63ac8e3</originalsourceid><addsrcrecordid>eNp10LFOwzAQBmALgUQpDLyBJRYY0p7tJLZZUFXRghSJJcyW6zo0VZoUO1XJxiPwLDwID8GTYAgTEjecl-_Opx-hcwIjEmqsq2pEYpkmB2hAmBSRlDI5RAMgkERxwsQxOvF-DQCcShggma8szuezz9e3j_fQ8hXF-qX013iCa7vHrXZPtsVF47DRtbEOtyvr9La7OUVHha68Pft9h-hxdptP76LsYX4_nWSRYSz8STjnQqYQU0YMJFzQ5YIXmnBiKTVQSC6FFsLw0OJluoQYCrqAhShSpo2wbIgu-71b1zzvrG_VpvTGVpWubbPziiYsTgmHBAK9-EPXzc7V4bqgRCpAhArqqlfGNd47W6itKzfadYqA-g5RhRDVT4jBjnu7Lyvb_Q_VJMv6iS_H-XGi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2586808888</pqid></control><display><type>article</type><title>The TGF‐β‐Th2 axis: A new target for cancer therapy?</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>García de Durango, Cira Rosario ; Escribese, Maria M. ; Rosace, Domenico</creator><creatorcontrib>García de Durango, Cira Rosario ; Escribese, Maria M. ; Rosace, Domenico</creatorcontrib><identifier>ISSN: 0105-4538</identifier><identifier>EISSN: 1398-9995</identifier><identifier>DOI: 10.1111/all.14965</identifier><language>eng</language><publisher>Zurich: Blackwell Publishing Ltd</publisher><subject>cancer ; Cancer therapies ; hypoxia ; IL‐4 ; Lymphocytes T ; TGF‐β ; type 2 immunity</subject><ispartof>Allergy (Copenhagen), 2021-11, Vol.76 (11), p.3563-3565</ispartof><rights>2021 European Academy of Allergy and Clinical Immunology and John Wiley &amp; Sons Ltd</rights><rights>2021 EAACI and John Wiley and Sons A/S</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3305-177789604231c05782db7fa171e22c0f9798a88c7a884d6d040f2b0b8f63ac8e3</citedby><cites>FETCH-LOGICAL-c3305-177789604231c05782db7fa171e22c0f9798a88c7a884d6d040f2b0b8f63ac8e3</cites><orcidid>0000-0001-5057-5150 ; 0000-0002-1076-0148 ; 0000-0002-8833-8422</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fall.14965$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fall.14965$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27903,27904,45553,45554,46388,46812</link.rule.ids></links><search><creatorcontrib>García de Durango, Cira Rosario</creatorcontrib><creatorcontrib>Escribese, Maria M.</creatorcontrib><creatorcontrib>Rosace, Domenico</creatorcontrib><title>The TGF‐β‐Th2 axis: A new target for cancer therapy?</title><title>Allergy (Copenhagen)</title><subject>cancer</subject><subject>Cancer therapies</subject><subject>hypoxia</subject><subject>IL‐4</subject><subject>Lymphocytes T</subject><subject>TGF‐β</subject><subject>type 2 immunity</subject><issn>0105-4538</issn><issn>1398-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp10LFOwzAQBmALgUQpDLyBJRYY0p7tJLZZUFXRghSJJcyW6zo0VZoUO1XJxiPwLDwID8GTYAgTEjecl-_Opx-hcwIjEmqsq2pEYpkmB2hAmBSRlDI5RAMgkERxwsQxOvF-DQCcShggma8szuezz9e3j_fQ8hXF-qX013iCa7vHrXZPtsVF47DRtbEOtyvr9La7OUVHha68Pft9h-hxdptP76LsYX4_nWSRYSz8STjnQqYQU0YMJFzQ5YIXmnBiKTVQSC6FFsLw0OJluoQYCrqAhShSpo2wbIgu-71b1zzvrG_VpvTGVpWubbPziiYsTgmHBAK9-EPXzc7V4bqgRCpAhArqqlfGNd47W6itKzfadYqA-g5RhRDVT4jBjnu7Lyvb_Q_VJMv6iS_H-XGi</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>García de Durango, Cira Rosario</creator><creator>Escribese, Maria M.</creator><creator>Rosace, Domenico</creator><general>Blackwell Publishing Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5057-5150</orcidid><orcidid>https://orcid.org/0000-0002-1076-0148</orcidid><orcidid>https://orcid.org/0000-0002-8833-8422</orcidid></search><sort><creationdate>202111</creationdate><title>The TGF‐β‐Th2 axis: A new target for cancer therapy?</title><author>García de Durango, Cira Rosario ; Escribese, Maria M. ; Rosace, Domenico</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3305-177789604231c05782db7fa171e22c0f9798a88c7a884d6d040f2b0b8f63ac8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>cancer</topic><topic>Cancer therapies</topic><topic>hypoxia</topic><topic>IL‐4</topic><topic>Lymphocytes T</topic><topic>TGF‐β</topic><topic>type 2 immunity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>García de Durango, Cira Rosario</creatorcontrib><creatorcontrib>Escribese, Maria M.</creatorcontrib><creatorcontrib>Rosace, Domenico</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Allergy (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>García de Durango, Cira Rosario</au><au>Escribese, Maria M.</au><au>Rosace, Domenico</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The TGF‐β‐Th2 axis: A new target for cancer therapy?</atitle><jtitle>Allergy (Copenhagen)</jtitle><date>2021-11</date><risdate>2021</risdate><volume>76</volume><issue>11</issue><spage>3563</spage><epage>3565</epage><pages>3563-3565</pages><issn>0105-4538</issn><eissn>1398-9995</eissn><cop>Zurich</cop><pub>Blackwell Publishing Ltd</pub><doi>10.1111/all.14965</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-5057-5150</orcidid><orcidid>https://orcid.org/0000-0002-1076-0148</orcidid><orcidid>https://orcid.org/0000-0002-8833-8422</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0105-4538
ispartof Allergy (Copenhagen), 2021-11, Vol.76 (11), p.3563-3565
issn 0105-4538
1398-9995
language eng
recordid cdi_proquest_miscellaneous_2534617050
source Wiley Online Library Journals Frontfile Complete; Wiley Free Content; EZB-FREE-00999 freely available EZB journals
subjects cancer
Cancer therapies
hypoxia
IL‐4
Lymphocytes T
TGF‐β
type 2 immunity
title The TGF‐β‐Th2 axis: A new target for cancer therapy?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T22%3A07%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20TGF%E2%80%90%CE%B2%E2%80%90Th2%20axis:%20A%20new%20target%20for%20cancer%20therapy?&rft.jtitle=Allergy%20(Copenhagen)&rft.au=Garc%C3%ADa%20de%20Durango,%20Cira%20Rosario&rft.date=2021-11&rft.volume=76&rft.issue=11&rft.spage=3563&rft.epage=3565&rft.pages=3563-3565&rft.issn=0105-4538&rft.eissn=1398-9995&rft_id=info:doi/10.1111/all.14965&rft_dat=%3Cproquest_cross%3E2534617050%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2586808888&rft_id=info:pmid/&rfr_iscdi=true